BioCentury
ARTICLE | Distillery Therapeutics

Neurology

March 7, 2018 12:47 AM UTC

Cell culture and mouse studies suggest inhibiting necroptosis could help treat PD in patients harboring OPA1 mutations. In three neural progenitor cell lines derived from a patient harboring OPA1 muta...

BCIQ Target Profiles

Optic atrophy 1 (OPA1)